Novo Nordisk Looks to Expand Latin American Obesity Business Novo Nordisk Looks to Expand Latin American Obesity Business

Danish drugmaker Novo Nordisk is looking to expand its obesity business in Latin America on the back of"phenomenal" performance by its new anti-obesity injection Saxenda (liraglutide), a senior company official said on Monday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news